120 related articles for article (PubMed ID: 9204382)
1. Differentiation between various types of inotropes through discovery of differences in their ability to detect isoforms of Na+/K(+)-ATPase.
Repke KR; Megges R; Weiland J
J Enzyme Inhib; 1997 Apr; 12(1):53-8. PubMed ID: 9204382
[No Abstract] [Full Text] [Related]
2. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
3. Axonal contact regulates expression of alpha2 and beta2 isoforms of Na+, K+-ATPase in Schwann cells: adhesion molecules and nerve regeneration.
Kawai H; Yasuda H; Terada M; Omatsu-Kanbe M; Kikkawa R
J Neurochem; 1997 Jul; 69(1):330-9. PubMed ID: 9202327
[TBL] [Abstract][Full Text] [Related]
4. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
Oselkin M; Tian D; Bergold PJ
Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
[TBL] [Abstract][Full Text] [Related]
5. Role of endosomal Na+-K+-ATPase and cardiac steroids in the regulation of endocytosis.
Feldmann T; Glukmann V; Medvenev E; Shpolansky U; Galili D; Lichtstein D; Rosen H
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C885-96. PubMed ID: 17553933
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
Fedorova OV; Bagrov AY
Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
[TBL] [Abstract][Full Text] [Related]
7. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.
Bagrov AY; Shapiro JI; Fedorova OV
Pharmacol Rev; 2009 Mar; 61(1):9-38. PubMed ID: 19325075
[TBL] [Abstract][Full Text] [Related]
8. Endogenous cardiotonic steroids.
Schoner W
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
[TBL] [Abstract][Full Text] [Related]
9. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
[TBL] [Abstract][Full Text] [Related]
10. Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.
Wansapura AN; Lasko V; Xie Z; Fedorova OV; Bagrov AY; Lingrel JB; Lorenz JN
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1833-9. PubMed ID: 19376809
[TBL] [Abstract][Full Text] [Related]
11. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
[TBL] [Abstract][Full Text] [Related]
12. Alterations of Na,K-ATPase isoenzymes in the rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids.
Gerbi A; Maixent JM; Barbey O; Jamme I; Pierlovisi M; Coste T; Pieroni G; Nouvelot A; Vague P; Raccah D
J Neurochem; 1998 Aug; 71(2):732-40. PubMed ID: 9681464
[TBL] [Abstract][Full Text] [Related]
13. Selective ligands for Na
Chakraborty D; Fedorova OV; Bagrov AY; Kaphzan H
Neuropharmacology; 2017 May; 117():338-351. PubMed ID: 28232062
[TBL] [Abstract][Full Text] [Related]
14. Modulators of Na/K-ATPase: a patent review.
Wang HY; O'Doherty GA
Expert Opin Ther Pat; 2012 Jun; 22(6):587-605. PubMed ID: 22595010
[TBL] [Abstract][Full Text] [Related]
15. Istaroxime, a novel luso-inotropic agent for the treatment of acute heart failure.
Wehrens XH
Curr Opin Investig Drugs; 2007 Sep; 8(9):769-77. PubMed ID: 17729189
[TBL] [Abstract][Full Text] [Related]
16. 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action.
Pôças ES; Costa PR; da Silva AJ; Noël F
Biochem Pharmacol; 2003 Dec; 66(11):2169-76. PubMed ID: 14609741
[TBL] [Abstract][Full Text] [Related]
17. Mechanism underlying the strong positive inotropic effects of LND-623: specific inhibition of Na, K-ATPase isoforms and exclusion of cellular sites of contractile control.
Maixent JM; Lelièvre L; Berrebi-Bertrand I
Cardiovasc Drugs Ther; 1998 Dec; 12(6):585-94. PubMed ID: 10410828
[TBL] [Abstract][Full Text] [Related]
18. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
[TBL] [Abstract][Full Text] [Related]
19. All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides.
Wang J; Velotta JB; McDonough AA; Farley RA
Am J Physiol Cell Physiol; 2001 Oct; 281(4):C1336-43. PubMed ID: 11546672
[TBL] [Abstract][Full Text] [Related]
20. Conformational states of the pig kidney Na
Azalim P; do Monte FM; Rendeiro MM; Liu X; O'Doherty GA; Fontes CF; Leitão SG; Quintas LEM; Noël F
Biochem Pharmacol; 2020 Jan; 171():113679. PubMed ID: 31669257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
